Delgado JF - Search Results

1

Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients.

Pascual J, Royuela A, Fernández AM, Herrero I, Delgado JF, Solé A, Guirado L, Serrano T, de la Torre-Cisneros J, Moreno A, Cordero E, Gallego R, Lumbreras C, Aguado JM; Spanish Society of Transplantation Virological and Immune Response Investigation Study Group. Pascual J, et al. Among authors: delgado jf. Transpl Infect Dis. 2016 Dec;18(6):819-831. doi: 10.1111/tid.12601. Epub 2016 Oct 19. Transpl Infect Dis. 2016. PMID: 27600985 Review.

2

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

Aguado JM, Gomez-Sanchez MA, Lumbreras C, Delgado J, Lizasoain M, Otero JR, Rufilanchas JJ, Noriega AR. Aguado JM, et al. Antimicrob Agents Chemother. 1995 Jul;39(7):1643-5. doi: 10.1128/AAC.39.7.1643. Antimicrob Agents Chemother. 1995. PMID: 7492123 Free PMC article. Clinical Trial.

3

Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?

Delgado J, Muñoz de Bustillo E, Ibarrola C, Colina F, Morales JM, Rodriguez E, Aguado JM, Fuertes A, Gomez MA. Delgado J, et al. J Heart Lung Transplant. 1999 Jun;18(6):607-10. doi: 10.1016/s1053-2498(98)00019-9. J Heart Lung Transplant. 1999. PMID: 10395359

4

Efficacy and safety of valgancyclovir as preemptive therapy for the prevention of cytomegalovirus disease in solid organ transplant recipients.

Díaz-Pedroche C, Lumbreras C, Del Valle P, San Juan R, Hernando S, Folgueira D, Andrés A, Delgado J, Meneu JC, Morales JM, Moreno E, Aguado JM. Díaz-Pedroche C, et al. Transplant Proc. 2005 Nov;37(9):3766-7. doi: 10.1016/j.transproceed.2005.10.075. Transplant Proc. 2005. PMID: 16386532 Clinical Trial.

5

Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.

Hernando S, Folgueira L, Lumbreras C, San Juan R, Maldonado S, Prieto C, Babiano MJ, Delgado J, Andres A, Moreno E, Aguado JM, Otero JR. Hernando S, et al. Transplant Proc. 2005 Nov;37(9):4094-6. doi: 10.1016/j.transproceed.2005.10.087. Transplant Proc. 2005. PMID: 16386635

6

Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients.

Delgado JF, Torres J, José Ruiz-Cano M, Sánchez V, Escribano P, Borruel S, María Cortina J, de la Calzada CS. Delgado JF, et al. J Heart Lung Transplant. 2006 Sep;25(9):1171-4. doi: 10.1016/j.healun.2006.05.013. J Heart Lung Transplant. 2006. PMID: 16962483

7

Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study.

López-Medrano F, Aguado JM, Lizasoain M, Folgueira D, Juan RS, Díaz-Pedroche C, Lumbreras C, Morales JM, Delgado JF, Moreno-González E. López-Medrano F, et al. Among authors: delgado jf. Transplantation. 2007 Oct 15;84(7):851-6. doi: 10.1097/01.tp.0000282788.70383.8b. Transplantation. 2007. PMID: 17984837

8

A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients.

San Juan R, Yebra M, Lumbreras C, López-Medrano F, Lizasoain M, Meneu JC, Delgado J, Andrés A, Aguado JM. San Juan R, et al. Clin Transplant. 2009 Sep-Oct;23(5):666-71. doi: 10.1111/j.1399-0012.2009.01077.x. Epub 2009 Aug 17. Clin Transplant. 2009. PMID: 19689451

9

Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?

Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Gonzalez-Vilchez F, et al. Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23. Int J Cardiol. 2014. PMID: 24309084

10

The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

Roman A, Manito N, Campistol JM, Cuervas-Mons V, Almenar L, Arias M, Casafont F, del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Serón D, Ussetti P; ATOS working group. Roman A, et al. Among authors: delgado jf. Transplant Rev (Orlando). 2014 Apr;28(2):84-91. doi: 10.1016/j.trre.2014.01.001. Epub 2014 Jan 27. Transplant Rev (Orlando). 2014. PMID: 24602805 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters